Is the third generation EGFR TKIs the solution for making EGFR mutant NSCLC a curable disease?
Saved in:
Published in | Translational lung cancer research Vol. 3; no. 6; pp. 363 - 364 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
China
Pioneer Bioscience Publishing Company
01.12.2014
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2218-6751 2226-4477 |
---|---|
DOI: | 10.3978/j.issn.2218-6751.2014.11.07 |